✦ LIBER ✦

413 POSTER A multicenter phase II study of Epirubicin (E) with low-dose herceptin (LD-H) as a first line treatment in HER-2 overexpressing metastatic breast cancer (MBC): Preliminary results

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P101 A multicenter phase II study of Epi

✍ M. De Tursi; C. Carella; E. Ricevuto; A. Gennari; C. Orlandini; A. Frassoldati; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A multicenter phase II study of epirubic

✍ M. Zilli; De Tursi; C. Carella; E. Ricevuto; P. Marchetti; A. Gennari; C. Orland 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A multinational phase II study of Navelb

✍ M Untch; S Kahlert; L Petruzelka; M Martin; V Guillem-Porta; M Gil; P Kellokumpu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II study with dose finding of Oral

✍ F. Nolè; Catania; G. Sanna; R. Mattioli; D. Crivellari; P. Foa; G. Pinotti; D. L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

446 PUBLICATION A phase II trial of tras

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB